Co-treatment with TNF-α and DEX effectively blocked TNF-α-induced apoptosis by inhibiting XIAP, c-IAP1, and c-IAP2 cleavage in human breast cancer cells (MCF-7) [9]. Here, TNF is linked to breast carcinoma.